We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Eric Farias Lockwood has been assisting clients through the H1B Visa process since 2022.

As of 2022, Eric Farias Lockwood has succesfully submitted and recieved certification for 71 cases.

Eric Farias Lockwood is located in Boston, MA, and has represented 32 employers for the H1B Visa Process

74
Cases Handled
71
Cases Certified
95.95%
Approval

Cases Handled by Eric Farias Lockwood

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-23163-100057 Certified Secondary School Teachers Except Special And Careertechnical Education Elementary And Secondary Schools Newton Country Day School Of The Sacred Heart 2023
I-200-22308-569344 Certified Health Specialties Teachers Postsecondary Colleges Universities And Professional Schools New England College Of Optometry 2023
I-200-23256-344200 Certified Rehabilitation Counselors Administration Of Education Programs New England Center For Children Inc 2023
I-200-23052-790631 Certified Rehabilitation Counselors Administration Of Education Programs New England Center For Children Inc 2023
I-200-22118-117096 Certified Economists Pharmaceutical Preparation Manufacturing Emd Serono Research And Development Institute Inc 2022
I-200-22158-253153 Certified Chemists Research And Development In Biotechnology Except Nanobiotechnology Foghorn Therapeutics Inc 2022
I-200-22158-254224 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Corbus Pharmaceuticals Inc 2022
I-200-22153-235411 Certified Chemists Research And Development In The Physical Engineering And Life Sciences Sigma Aldrich Manufacturing Llc 2022
I-200-23257-346375 Certified Chemists Semiconductor And Other Electronic Component Manufacturing Versum Materials Us Llc 2023
I-200-23137-028964 Certified Medical Scientists Except Epidemiologists Research And Development In Biotechnology Except Nanobiotechnology Foghorn Therapeutics Inc 2023